Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations
Constantina Rodica Popa, Dominique Hervé, Nassira Alili, Estelle Dubus, Abbas Taleb, Fanny Fernandes, Florence Riant, Elisabeth Tournier Lasserve, Louis Lambert, Hugues Chabriat, Stéphanie GueyABSTRACT
Background and Purpose
Familial cerebral cavernous malformations (fCCM) may cause focal neurological deficits (FND) due to hemorrhagic or non‐hemorrhagic events and epileptic seizures (ES). With the widespread use of magnetic resonance imaging (MRI) and genetic testing, diagnosis is now frequently established at a presymptomatic stage, before any clinical manifestation. However, the subsequent risk of a first clinical event in these individuals remains poorly defined.
Methods
We conducted a cohort‐based analysis of retrospectively collected longitudinal data from 79 patients with fCCM who were asymptomatic at diagnosis (median age, 41.7 years) and managed in a national referral center.
Results
Over 649.6 patient‐years (median follow‐up, 4.0 years), 23 patients (29%) experienced a first clinical event. Post‐diagnostic event‐free survival was approximately 97% at 1 year, 79% at 5 years, and 69% at 10 years. Incidence rates for a first event were 35.4 per 1000 person‐years for any first event (FND or ES), 23.1 per 1000 person‐years for a first FND, and 15.4 per 1000 person‐years for a first ES. Male sex was independently associated with higher risk (HR 4.20; 95% CI, 1.60–11.04; p = 0.0036).
Conclusions
These data provide pragmatic post‐diagnostic risk estimates to guide counseling and surveillance in asymptomatic fCCM.